DIRS.INFO The most relevant business & tech news

[1/3] FILE PHOTO:Surgeon Rosanna Curinga walks out of Locri Hospital, in Locri, southern Italy, August 27, 2023. Italy's health ministry declined to provide further details. People are leaving Italy because of it," said Professor Foad Aodi, head of the Italian association of foreign doctors. The COVID-19 pandemic laid bare the failings of the national health service in Italy, which suffered the second-highest death toll from the pandemic in Europe after Britain. Higher salaries and better working conditions elsewhere are also proving a lure for Italy's own medical professionals, Italy's health unions say, exacerbating staff shortages.

Persons: Rosanna Curinga, Curinga, Abdel Karim Boutimah, Elizabeth Balbuena Delgado, Delgado, Orazio Schillaci, Schillaci, Giorgia Meloni, Andrea Filippi, Foad Aodi, Roberto Occhiuto, Occhiuto, Lorenzo Grillo Della Berta, Antonio De Palma, Francesca Piscioneri, Crispian Balmer, Rupam Nair, Daniel Flynn Organizations: Locri, Cuban, Indian Health Ministry, Italian, Economic Co, Development, Reuters, Union, OECD, Thomson Locations: Locri, Italy, Calabria, Communist Cuba, Africa, Asia, South America, Europe, Santiago de Cuba, Italy's, India, Paris, France, Germany, Britain, Havana, COVID, Morbegno, Milan, Peru, Switzerland, Abu Dhabi, Antonio De Palma ., Cuba, Rome, Delhi

The World Health Organization said last year the syrups, made by Indian manufacturer Maiden Pharmaceuticals Ltd, contained lethal toxins ethylene glycol (EG) and diethylene glycol (DEG) – used in car brake fluid. "If you ask and you don't get informed, it's a dead end," Rutendo Kuwana, the WHO's team lead for incidents with substandard and falsified medicines, told Reuters in an interview on March 31. Drug inspectors found a dozen violations at Maiden last October related to the production of the cough syrups sold to Gambia, a government document showed. Among these, some of the COAs of raw ingredients used in making the syrups, including propylene glycol, were missing batch numbers. Kuwana said the WHO was sure of its own cough syrup test results from two separate independent laboratories, both of which showed contamination.

☆ Exclusive: India may issue alert on Marion cough syrup exports after toxins found
▼ + stars: | 2023-03-04 | by ( Krishna N. Das | ) www.reuters.com time to read: +3 min

[1/2] Logo of Marion Biotech, a healthcare and pharmaceutical company is seen on a gate outside their office in Noida, India, December 29, 2022. REUTERS/Anushree FadnavisNEW DELHI, March 4 (Reuters) - India may issue an alert on cough syrup exported by Marion Biotech, whose products have been linked to deaths in Uzbekistan, after tests showed many of the company's drug samples contained toxins, a drug inspector said on Saturday. "The health ministry could issue an alert. Babbar has been part of a team that inspected Marion's plant four times after Uzbekistan said in December the children died after consuming the company's cough syrups. India in October suspended production at Maiden for violating manufacturing standards after the WHO said four of its cough syrups may have killed dozens of children in Gambia.

☆ Indian maker of syrup linked to Uzbekistan deaths halts production; facility inspected
▼ + stars: | 2022-12-29 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Anushree FadnavisNEW DELHI, Dec 29 (Reuters) - India's drug regulator said on Thursday that it had inspected Marion Biotech's production facility and promised more action based on the probe report after the company's cough syrup was linked to death of 18 children in Uzbekistan. A legal representative of Marion Biotech said the Indian maker of pharmaceuticals and cosmetics regretted the deaths and the company has halted production of the Dok-1 Max syrup. The drug regulator reviewed the company's Noida facility in the Uttar Pradesh state and is in regular touch with its Uzbekistan counterpart, the Indian health ministry said in a statement. "The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory, Chandigarh for testing," the ministry said. Uzbekistan's health ministry said on Wednesday that at least 18 children in the country died after consuming the syrup, manufactured by the Indian drugmaker.

The WHO suspects that four of the syrups made by Maiden Pharmaceuticals Limited – Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup – have “unacceptable amounts” of chemicals that can damage the brain, lungs, liver and kidneys of those who take them. The deaths confounded medics until a pattern emerged: dozens of patients younger than five had fallen ill three to five days after taking a locally sold syrup made by Maiden Pharmaceuticals. CNN has reached out to Maiden Pharmaceuticals Limited, but has not yet heard back. All of the children had consumed Maiden Pharmaceuticals’ cough syrups, authorities added. One official told Reuters that the total number of deaths nationwide was “still being determined.”Indonesia’s Food and Drug Monitoring Agency said this week that the cough syrups had not been registered in the country.

Search resuls for: "Indian Health Ministry"

5 mentions found